Ocular Therapeutix OCUL Insider Ownership

NASDAQ OCUL

$6.48 -0.17 (-2.56%)

At close: Oct 21, 2026 · 4:00 PM EDT

Insider Holdings by Owner

15.44Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

2.80%

▼-0.012% pp QoQ

Shares Held by Insiders

6.29Mn

filed for Sep 2026

▼-0.43% QoQ

Shares Outstanding

224.95Mn

224,952,428 shares

Direct Holdings

5.54Mn

Indirect: 744.90K

Net Shares Traded (QoQ)

-27.16K

net selling in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 16, 2026

Over the past 12 months, Ocular Therapeutix insiders bought $461,354 of stock on the open market (60.23K shares) and sold $3.3 million (358.62K shares).

A count shows one insider buying OCUL stock on the open market over the past 12 months and 8 insiders selling.
Among OCUL's insiders, Richard L. Lindstrom (Director) was the top open-market buyer in the past 12 months, with $461,354 of stock purchased (60.23K shares) and the latest purchase on February 20, 2026.
On the selling side, Pravin Dugel (Director and officer) sold the most Ocular Therapeutix stock on the open market over the past 12 months, $1.94 million (207.27K shares), most recently on August 24, 2026.
The latest open-market trade in OCUL stock by an insider was a sale of 11.98K shares for $87,363 by Todd Anderman (Chief Legal Officer) on October 8, 2026.
Beyond open-market trades, insiders at Ocular Therapeutix received 309.45K shares in stock awards and gave away 939.33K shares as gifts in the last 12 months.
Per Business Quant, OCUL insiders together hold 6.26Mn shares based on their latest Form 4 filings, down 0.95% from 6.32Mn shares at the end of Q2 2026.
Of the 6.26Mn shares held by Ocular Therapeutix insiders, 5.51Mn shares (88.09%) are held directly and 744.9K shares (11.91%) indirectly, through trusts, partnerships, family members and other entities.
Per Business Quant, 17 insiders of OCUL hold shares, counting officers, directors and 10% owners who have filed a Form 4 in the past two years.
Ocular Therapeutix's three biggest insider holders are Pravin Dugel (Director and officer, 3.27Mn shares), Donald Notman (Chief Operating Officer, 366.53K shares) and Sanjay Nayak (Chief Strategy Officer, 326.9K shares), based on their latest Form 4 filings.
The largest insider, Pravin Dugel, holds 52.28% of OCUL's insider total.
Institutional holders reported 90.93% of Ocular Therapeutix's outstanding shares for Q2 2026; insiders' latest Form 4 filings put their stake at about 2.78%, and other investors, including the public, hold the remaining 6.29%.
In the past year, 17 insiders of Ocular Therapeutix submitted 48 Form 4 filings reporting trades, awards or other transactions.
Insider figures for OCUL include Form 4 filings through October 13, 2026.

Form 4 Holdings

Insiders Holding OCUL

Insiders 23

Shares held 15.44Mn

Of outstanding 6.86%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	Road Llc Summer	TenPercentOwner	0	8,591,401	8,591,401	55.6%	27 Feb, 2024
2	Pravin Dugel	Executive Chairman	2,525,429	0	2,525,429	16.4%	26 Aug, 2026
3	Antony C. Mattessich	President And Ceo	588,701	0	588,701	3.8%	06 Feb, 2024
4	Donald Notman	Chief Operating Officer	366,529	0	366,529	2.4%	02 Sep, 2026
5	Sanjay Nayak	Chief Strategy Officer	326,898	0	326,898	2.1%	26 Aug, 2026
6	Michael H. Goldstein	President, Ophthalmology Cmo	313,335	0	313,335	2.0%	07 Feb, 2022
7	Jeffrey S. Heier	Chief Scientific Officer	307,457	0	307,457	2.0%	06 Oct, 2026
8	Nadia Waheed	Chief Medical Officer	300,079	0	300,079	1.9%	05 Jun, 2026
9	Richard L Md Lindstrom	Director	260,933	0	260,933	1.7%	12 Jun, 2026
10	Namrata Saroj	Chief Business Officer	254,620	0	254,620	1.6%	06 Jan, 2026
11	Peter Kaiser	Chief Development Officer	254,388	0	254,388	1.6%	06 Oct, 2026
12	Steve Lawrence Meyers	Chief Commercial Officer	217,628	0	217,628	1.4%	06 Jan, 2026
13	Philip C. Strassburger	General Counsel	161,493	0	161,493	1.0%	06 Feb, 2024
14	Rabia Gurses Ozden	Chief Medical Officer	153,054	0	153,054	1.0%	06 Feb, 2024
15	Todd Anderman	Chief Legal Officer	140,484	0	140,484	0.9%	13 Oct, 2026
16	David Wayne Robinson	Global Cco	136,000	0	136,000	0.9%	26 Jan, 2026
17	Christopher G White	Chief Business Officer	123,689	0	123,689	0.8%	06 Feb, 2024
18	Charles M Warden	Director	100,464	0	100,464	0.7%	12 Jun, 2026
19	Jason Shand Robins	Chief Financial Officer	68,097	0	68,097	0.4%	12 Jun, 2026
20	Leslie J. Williams	Director	65,433	0	65,433	0.4%	12 Jun, 2026
21	Adrienne L Graves	Director	64,000	0	64,000	0.4%	12 Jun, 2026
22	Seung Suh Hong	Director	60,933	0	60,933	0.4%	12 Jun, 2026
23	Merilee Raines	Director	60,933	0	60,933	0.4%	12 Jun, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

509 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
08 Oct, 2026	Todd Anderman	Chief Legal Officer	Disposed S	11,984	$7.29	$87.36K	140,484	Direct
02 Oct, 2026	Peter Kaiser	Chief Development Officer	Disposed S	9,990	$7.05	$70.43K	254,388	Direct
02 Oct, 2026	Jeffrey S. Heier	Chief Scientific Officer	Disposed S	10,869	$7.05	$76.63K	307,457	Direct
31 Aug, 2026	Donald Notman	Chief Operating Officer	Disposed S	1,099	$10.24	$11.25K	366,529	Direct
24 Aug, 2026	Peter Kaiser	Chief Development Officer	Disposed S	3,035	$10.77	$32.69K	264,378	Direct
24 Aug, 2026	Jeffrey S. Heier	Chief Scientific Officer	Disposed S	3,296	$10.78	$35.53K	318,326	Direct
24 Aug, 2026	Sanjay Nayak	Chief Strategy Officer	Disposed S	1,897	$10.78	$20.45K	326,898	Direct
24 Aug, 2026	Pravin Dugel	Director, Officer	Disposed S	21,649	$10.77	$233.16K	2,525,429	Direct
25 Aug, 2026	Pravin Dugel	Director, Officer	Disposed G	50,092	$0.00	$0	0	Indirect
25 Aug, 2026	Pravin Dugel	Director, Officer	Acquired G	50,092	$0.00	$0	744,903	Indirect
16 Jun, 2026	Pravin Dugel	Director, Officer	Disposed G	50,092	$0.00	$0	2,547,078	Direct
16 Jun, 2026	Pravin Dugel	Director, Officer	Acquired G	50,092	$0.00	$0	50,092	Indirect
10 Jun, 2026	Merilee Raines	Director	Acquired A	14,000	$0.00	$0	60,933	Direct
10 Jun, 2026	Jason Shand Robins	Chief Financial Officer	Acquired A	15,441	$0.00	$0	68,097	Direct
10 Jun, 2026	Adrienne L Graves	Director	Acquired A	14,000	$0.00	$0	64,000	Direct
10 Jun, 2026	Charles M Warden	Director	Acquired A	14,000	$0.00	$0	100,464	Direct
10 Jun, 2026	Richard L Md Lindstrom	Director	Acquired A	14,000	$0.00	$0	260,933	Direct
10 Jun, 2026	Leslie J. Williams	Director	Acquired A	14,000	$0.00	$0	65,433	Direct
10 Jun, 2026	Seung Suh Hong	Director	Acquired A	14,000	$0.00	$0	60,933	Direct
10 Jun, 2026	Adrienne L Graves	Director	Acquired A	44,000	$0.00	$0	44,000	Direct

Showing 1 to 20 of 509 transactions